Tag Archives: Ontario

BlissCo Cannabis

Supreme Makes Strategic Investment in Distribution Partner and Secures Supply Agreement with BlissCo

Supreme Makes Strategic Investment in Distribution Partner and Secures Supply Agreement with BlissCo

TORONTO, Ontario, Feb. 26, 2018 /Weed Wire/ — The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSXV:FIRE), is pleased to announce that it has completed a $3,000,000 strategic equity investment (the “Investment”) in BlissCo Cannabis Corp. (“BlissCo”).

GrowPros

Tetra Bio-Pharma Announces the Completion of GrowPros Transaction

OTTAWA, Ontario, Feb. 22, 2018 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce the completion of the sale of its shares of GrowPros MMP Inc. (“GrowPros”) to North Bud Farms Inc. (the “Purchaser” or “North Bud”) as previously announced in Tetra’s December 21st, 2017 press release.

CCI

CANNABIS COMPLIANCE INC. (CCI) announces successful retail licence for its client National Access Cannabis (NAC) and gears up for private retail consulting.

TORONTO, Ontario, Feb. 22, 2018 /Weed Wire/ – CANNABIS COMPLIANCE INC. (CCI) of Toronto, Ontario, Canada, is pleased to announce the conditional acceptance for securing cannabis retail licence in Manitoba for National Access Cannabis (NAC).

Ontario Selects Shopify to Run Mobile and Online Cannabis Sales

Ontario Selects Shopify to Run Mobile and Online Cannabis Sales

With Canadian cannabis legalization slated to commence this summer, Ontario has been proactive in its preparations, being the first province to issue its market regulations and now announcing a partnership with a popular ecommerce platform based in Ottawa to run mobile and online cannabis sales in the province.

Aphria Liberty Health sale agreement

Liberty Health Sciences Applauds CSA Notice Regarding Issuers With U.S. Cannabis Investments

TORONTO, Ontario, Feb. 9, 2018 /Weed Wire/ – Liberty Health Sciences Inc. (CSE: LHS or US OTCQX: LHSIF) (the “Company” or “Liberty”) is providing the following statement in response to the Canadian Securities Administration’s (the “CSA”) Staff Notice 51-352 Issuers with U.S. Marijuana-Related Activities (the “Notice”), revised February 8, 2018.

GrowPros

Tetra Bio-Pharma Announces $8 million Bought Deal Offering

ORLEANS, Ontario, Feb. 8, 2018 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP) (OTCQB:TBPMF) a global leader in cannabinoid-based drug development and discovery, announced today that it has entered into a bought deal financing agreement to sell 8,000,000 units of the Company (the “Units”) at a price of $1.00 per Unit for gross proceeds of approximately $8.0 million (the “Offering”).

Canadian Securities Regulators Publish Revised Disclosure Expectations for Issuers With US-Related Marijuana Activity

TORONTO, Ontario, Feb. 8, 2018 /Weed Wire/ – The Canadian Securities Administrators (CSA) today published CSA Staff Notice 51-352 (Revised) Issuers with U.S. Marijuana-Related Activities, which sets out CSA staff’s disclosure expectations for specific risks facing issuers with marijuana-related activities in the U.S.

Loyalist College Awarded Government of Ontario Grant to Advance its Applied Research Centre for Natural Products and Medical Cannabis (ARC)

BELLEVILLE, Ontario, Feb. 8, 2018 /Weed Wire/ – Loyalist College is pleased to announce that it has been awarded $660,000 in funding through the Government of Ontario’s Colleges Applied Research and Development Fund (CARDF).

SAQ

Tilray Announces Completion of Series A Funding Round

TORONTO, Ontario, Feb. 8, 2018 /Weed Wire/ – Tilray, a global pioneer in medical cannabis research, cultivation, processing and distribution, today announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors.

GrowPros

Tetra Bio-Pharma Receives Health Canada Phase 3 Clinical Trial Approval For Smokable Dried Cannabis Prescription Drug

OTTAWA, Ontario, Feb. 5, 2018 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD) Health Canada to its Clinical trial application (CTA) for the Company’s PPP001 prescription smokable dried cannabis product.

Aphria Liberty Health sale agreement

Liberty Health Sciences Announces New Strategic Investors With Proven Investment Experience In Cannabis Industry

TORONTO, Ontario, Feb. 5, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the “Company” or “Liberty”) is pleased to announce today that a group of buyers led by members of the Serruya family (the “Group”) has entered into a purchase and sale agreement with Aphria Inc.

Aphria Liberty Health

Aphria Begins to Divest of its Equity Investment in Passive US Assets

LEAMINGTON, Ontario, Feb. 5, 2018 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today announced that it entered into a purchase and sale agreement to sell 26,716,025 shares representing all its shares in Liberty Health Sciences Inc. (“Liberty”) that are not subject to Canadian Securities Exchange (“CSE”) escrow requirements.

Aphria Liberty Health sale agreement

Aphria And Liberty Health Sciences Announce Definitive Agreement For Sale Of Aphria’s Investment In Copperstate Farms To Liberty

LEAMINGTON AND TORONTO, Ontario, Feb. 2, 2018 /Weed Wire/ — Aphria Inc. (TSX:APH or OTCQB:APHQF) (“Aphria”) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) (“Liberty”) jointly announce that they have entered into a definitive agreement (the “Agreement”) with respect to the sale (the “Transaction”) of Aphria’s subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively “Copperstate”) to Liberty for a purchase price of $20 million (“Purchase Price”).

Aphria Liberty Health sale agreement

Liberty Health Sciences Announces Definitive Agreement For The Acquisition Of A 387-Acre Parcel Of Land In Gainesville, Florida

TORONTO, Ontario, Jan. 31, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) announced today that it has entered into a definitive share purchase agreement (the “Definitive Agreement”) with 242 Cannabis Canada Ltd. to acquire all of the issued and outstanding shares (the “Purchased Shares”) of its wholly-owned subsidiary, 242 Cannabis, LLC, a Florida limited liability company, which includes a 387-acre parcel of land in Gainesville, Florida (the “Property”) which was previously owned by Alico Citrus Nursery, LLC, a Florida limited liability company (“Alico”).

GrowPros

Tetra Bio-Pharma Receives Health Canada Approval for Phase 2 Cannabis Oil Trial in Partnership with Sante Cannabis

OTTAWA, Ontario, Jan. 29, 2018 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce the approval by Health Canada of a Phase 2 clinical trial designed to evaluate the safety and efficacy of different doses and ratios of medical cannabis oil (THC & CBD) to improve uncontrolled chronic pain in cancer and non-cancer patients.

Physical Security

Statement from Health Canada: Physical Security Requirements for Producers of Cannabis for Medical Purposes

OTTAWA, Ontario, Jan. 25, 2018 /Weed Wire/ – Health Canada is introducing two targeted changes to the physical security requirements under the Access to Cannabis for Medical Purposes Regulations (ACMPR) that must be respected by licensed producers (LP) of cannabis for medical purposes.

BlissCo Cannabis

Supreme Secures Supply Agreement with Namaste

TORONTO, Ontario, Jan. 25, 2018 /Weed Wire/ – The Supreme Cannabis Company, Inc. (the “Company” or “Supreme”) (TSXV:FIRE), is pleased to announce that its wholly-owned subsidiary, 8528934 Canada Ltd. (“7ACRES”), has entered into a Definitive Supply Agreement (the “Agreement”) with Cannmart, Inc. (“Cannmart”) a wholly-owned subsidiary of Namaste Technologies Inc.

Canadian Cannabis Research Banks $1.4M in Funding From Government

Canadian Cannabis Research Banks $1.4M in Funding From Government

With the Great White North preparing to become the first G7 nation to launch recreational legalization, the federal government wants to inform its journey into uncharted territory by providing $1.4 million in funding to Canadian cannabis research projects.

Physical Security

Government of Canada Invests in New Cannabis Research

TORONTO, Ontario, Jan. 24, 2018 /Weed Wire/ – The impact of non-medical cannabis use in Canada has been the subject of much speculation and debate. There are still many uncertainties related to the health, social, and economic implications of cannabis legalization and regulation. A solid evidence base is needed for the ongoing development of the most effective policies, practices, and programs relating to the use of cannabis and its derivatives.

Aphria Liberty Health sale agreement

Liberty Health Sciences Opens Inaugural Medical Cannabis Dispensary in Florida in The Villages

TORONTO, Ontario, Jan. 16, 2018 /Weed Wire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it has opened its inaugural medical cannabis dispensary in Florida, strategically located in The Villages, the state’s largest retirement community.

GrowPros

Tetra Bio-Pharma Receives Approval from Health Canada of its Phase 1 Clinical Trial with PPP005 (Cannabis Oil)

OTTAWA, Ontario, Jan. 16, 2018 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD), Health Canada to evaluate the safety, pharmacokinetics and pharmacodynamics of its cannabis oil PPP005.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Announces Proposed Acquisition of a 387 Acre Parcel of Land in Gainesville Including 200,000 Square Feet of Greenhouse and Processing Facilities

TORONTO, Ont., Jan. 4, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) announced today that it has entered into a binding term sheet to acquire all of the issued and outstanding shares of 242 Cannabis Canada Ltd. (the “242 Shares”), whose wholly-owned subsidiary 242 Cannabis, LLC, has agreed to purchase a 387 acre parcel of land in Gainesville, Florida (the “Property”).

Transition Sundial Growers Cannabis Canada Association

Cannabis Canada Association Announces Leadership Transition

OTTAWA, Ont., Jan. 4, 2018 /Weed Wire/ — The Board of Directors of Cannabis Canada Association (“Cannabis Canada”) today announced the departure of Colette Rivet from her position of Executive Director and the appointment of Allan Rewak as Acting Executive Director, while a comprehensive search for a permanent replacement is conducted.

GrowPros

Tetra Bio-Pharma Enters into Agreement to Acquire Remaining 20% Interest in Phytopain Pharma Subsidiary

OTTAWA, Ontario, Jan. 2, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development, today announced that it has entered into a share purchase agreement (the “Purchase Agreement”) with entities controlled by André Rancourt, Chairman of the Board of Directors of the Corporation, and Guy Chamberland, Chief Scientific Officer of the Corporation (collectively, the “Vendors”).

Khiron Receives Cultivation Quota From Colombian Government and Commences Cultivation

TORONTO, Ontario, Dec. 28, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that the Company’s wholly owned subsidiary, Khiron Colombia SAS, has commenced cultivation of a variety of medical grade cannabis strains in accordance with the receipt of its medical cannabis quota allocation provided by the Government of Colombia.

Aphria Bets C$10 Mln on Canada's Recreational Marijuana Market

Aphria Bets C$10 Mln on Canada’s Recreational Marijuana Market

Medical marijuana maker Aphria Inc said on Thursday it would invest C$10 million ($7.80 million) in the proposed combination of two recreational marijuana companies to expand its presence in the sector.

GrowPros

Tetra Bio-Pharma Announces the Signature of a Letter of Intent to Monetize GrowPros and its Late Stage ACMPR Application

OTTAWA, Ontario, Dec. 21, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) with a private Canadian corporation (the “Purchaser”) and has started a transaction to monetize GrowPros (GrowPros MMP Inc., Tetra’s wholly-owned subsidiary) (the “Potential Transaction”), to allow Tetra to focus its activities on the drug development and its clinical trials of its pharmaceutical business.

Physical Security

Health Canada Releases First Snapshot of Cannabis Use in Canada

OTTAWA, Ontario, Dec. 19, 2017 /Weed Wire/ — Between March and May 2017, Health Canada asked 9,215 Canadians about their knowledge, behaviours and attitudes towards cannabis use, including driving behaviours after consuming cannabis.

BlissCo Cannabis

Supreme Pharmaceuticals Inc. Changes Name to The Supreme Cannabis Company, Inc. and Announces Conversion of Approximately $17.4 Million Aggregate Principal Amount of 10% Unsecured Convertible Debentures Due 2019

TORONTO, Ontario, Dec. 18, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that is has changed its name to “The Supreme Cannabis Company, Inc.” effective today. The name change was approved by the shareholders of the Company at the annual general and special meeting of shareholders held earlier today.

BlissCo Cannabis

Supreme Purchases Adjacent Land for Ultra-Premium Cannabis Facility

TORONTO, Ontario, Dec. 18, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme or the “Company”) (TSXV:FIRE) is pleased to announce the purchase of an approximately six acre property adjacent to the 7ACRES facility in Kincardine, Ontario.

GrowPros

Tetra Bio-Pharma Reinforces its Development Program by Signing Research & Development Agreement with Constance Therapeutics and Receiving Financial Support from NSERC

OTTAWA, Ontario, Dec. 13, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that the company has signed an exclusive research and development (R&D) agreement with Constance Therapeutics.

Department of Canada: Proposed Excise Duty Framework for Cannabis Products and Finance Ministers

Finance Ministers Reach Agreements on Behalf of All Canadians

OTTAWA, Ont., Dec. 11, 2017 /Weed Wire/ — Canada works best when governments work collaboratively to take actions that are in the interest of all Canadians, strengthen the middle class and help those working hard to join it. Federal, provincial and territorial Finance Ministers met today in Ottawa to build on their productive partnership, discuss issues that are top of mind for Canadians, and make further progress on important joint priorities.

GrowPros

Tetra Bio-Pharma Opens Markets at TSX Listing Ceremony

OTTAWA, Ontario, Dec. 6, 2017 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development, is pleased to announce that Tetra opened the Toronto Stock Exchange (“TSX”) yesterday at a ceremony to recognize the listing and trading of Tetra, which began on August 16th 2017 under the symbol TBP.

Physical Security

Don’t Drive High: Public Awareness Campaign Launches Today

OTTAWA, Ontario, Dec. 5, 2017 /Weed Wire/ – Today, the Honourable Ralph Goodale, Minister of Public Safety and Emergency Preparedness, launched the Government of Canada’s drug-impaired driving public awareness campaign to communicate to Canadians the risks associated with driving under the influence of cannabis and other drugs.

Aphria Stock Soars Following Announcement of Medical Cannabis Deal With Shoppers Drug Mart

Aphria Stock Soars After Announcement of Cannabis Deal With Shoppers Drug Mart

Following market close on Dec. 4, 2017, Aphria Inc. (TSX:APH), an Ontario-based licensed producer of medical cannabis, made headlines when it announced that it had entered into an agreement to be the medical cannabis supplier for Shoppers Drug Mart, a Canadian pharmacy chain.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Moves to OTCQX Market

TORONTO, Ontario, Dec. 4, 2017 /Weed Wire/ – Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) an industry leading investor and operator in the U.S. medical cannabis market, announced today that it has qualified to trade on the OTCQX® Best Market, an OTC Markets Group Inc. financial market. Liberty upgraded to OTCQX from the Pink® market.

CCI

CCI Appoints Mr. Maurizio Calconi as Vice President for CCI Staffing Solutions, a division of Cannabis Compliance Inc.

OTTAWA, Ontario, Dec. 4, 2017 /Weed Wire/ – Cannabis Compliance Inc., (CCI) of Toronto, Ontario is pleased to announce the appointment of Mr. Maurizio Calconi to the CCI team as VP of CCI’s Staffing Solutions division.

CCI

CCI and NAC Announce Manitoba Tender Intentions

OTTAWA, Ontario, Dec. 4, 2017 /Weed Wire/ – Cannabis Compliance Inc. (“CCI”) is pleased to announce that it is working with National Access Cannabis Corp. (“NAC”), providing technical services in connection with NAC’s anticipated proposal to the Manitoba Request for Proposal for Retail Cannabis stores (RFP 10QGET-CRS-2017) (the “RFP”) due December 22, 2017.

AMO Calls on Ontario Government to Cover Municipal Cannabis Costs, Share New Taxes With Local Governments

TORONTO, Ont., Nov. 30, 2017 /Weed Wire/ — The Association of Municipalities of Ontario (AMO) President Lynn Dollin was at Queen’s Park today to request that the Government of Ontario cover municipal costs related to the legalization of cannabis, and provide municipalities with a share of tax revenues generated by cannabis sales.

BlissCo Cannabis

Supreme Signs High-Quality Flower Supply LOI Agreement with ABLE BC.

TORONTO, Ontario, Nov. 24, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce it has entered into a Letter of Intent (“LOI”) with the Alliance of Beverage Licensees (ABLE BC), the advocacy organization representing BC’s private liquor industry.

GrowPros

Tetra Bio-Pharma’s Business Model and Commercialization Strategy In Line with the Canadian Government’s Proposed Approach to the Regulation of Cannabis

OTTAWA, Ontario, Nov. 22, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that the Canadian Government’s Proposed Approach to the Regulation of Cannabis further confirms the strategic direction of its business model, and that the company is in an excellent position to commercialize natural health products and drugs post-legalization for both the pet and human markets.

Canadian Pharmacists Association ( CPhA )

Pharmacists Disappointed with Proposed Cannabis Regulations, Concerned with Impact to Medical Cannabis Patients

OTTAWA, Ontario, Nov. 22, 2017 /Weed Wire/ — The Canadian Pharmacists Association (CPhA) is disappointed that the federal government’s proposed regulatory approach to cannabis continues to miss the mark on several key issues, displaying an ongoing lack of concern for medical cannabis patients.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Announces Two Additional Dispensary Locations Have Been Secured In Florida

TORONTO, Ontario, Nov. 21, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) announced today that it has secured locations for two additional medical cannabis dispensaries in the State of Florida that are scheduled to open in early 2018.

Physical Security

Health Canada Launches Public Consultation on Proposed Approach to the Regulation of Cannabis

OTTAWA, Ont., Nov. 21, 2017 /Weed Wire/ — The current approach to cannabis does not work. Earlier this year, the Government of Canada introduced Bill C-45, the proposed Cannabis Act, to legalize, strictly regulate and restrict access to cannabis. Bill C-45 aims to keep cannabis out of the hands of Canadian youth and the profits away from criminals and organized crime.

Transition Sundial Growers Cannabis Canada Association

Statement on the Government of Québec’s plan for the Regulation of Cannabis

OTTAWA, Ontario, Nov. 21, 2017 /Weed Wire/ — Cannabis Canada, and the licensed producers of medical cannabis that it represents, share Province’s commitment to ensuring adult Quebecers have access to safe, regulated cannabis products and support the Government’s decision to make clear its intentions regarding the distribution and retail of adult-use cannabis.


Page 1 of 512345
Top